Inhibition of rabbit brain 4-aminobutyrate transaminase by some taurine analogues: A kinetic analysis

Biochemical Pharmacology

Volumn 71, Issue 10, 2006, Pages 1510-1519

  Ricci, Lorenzo ^a   Frosini, Maria ^a   Gaggelli, Nicola ^a   Valensin, Gianni ^a   Machetti, Fabrizio ^b   Sgaragli, Giampietro ^a   Valoti, Massimo ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

4 Aminobutyrate transaminase; 4 Aminobutyrate transaminase inhibitors; GABA; Taurine analogues; Vigabatrin

Indexed keywords

2 ACETYLAMINOCYCLOHEXANESULFONIC ACID; 2 AMINOBENZENESULFONIC ACID; 2 AMINOETHYLPHOSPHONIC ACID; 4 AMINOBUTYRATE AMINOTRANSFERASE; 4 AMINOBUTYRATE AMINOTRANSFERASE INHIBITOR; PIPERIDINE 3 SULFONIC ACID; PIPERIDINE DERIVATIVE; SULFONIC ACID DERIVATIVE; TAURINE DERIVATIVE; UNCLASSIFIED DRUG; VIGABATRIN;

ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; BRAIN SLICE; CHEMICAL ANALYSIS; COMPARATIVE STUDY; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PURIFICATION; EVALUATION; GABAERGIC TRANSMISSION; KINETICS; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RABBIT; STATISTICAL SIGNIFICANCE;

4-AMINOBUTYRATE TRANSAMINASE; AMINOETHYLPHOSPHONIC ACID; ANIMALS; ANTICONVULSANTS; BRAIN; ENZYME INHIBITORS; MALE; PIPERIDINES; RABBITS; SULFANILIC ACIDS; TAURINE; VIGABATRIN;

EID: 33646466675     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.02.007     Document Type: Article

References (64)

1. Baxter C.F., and Roberts E. The gamma-aminobutyric acid-alpha-ketoglutaric acid transaminase of beef brain. J Biol Chem 233 (1958) 1135-1139
2. Mehta P.K., and Christen P. The molecular evolution of pyridoxal-5′-phosphate-dependent enzymes. Adv Enzymol Relat Areas Mol Biol 74 (2000) 129-184
3. Cooper A.J.L. Glutamate-gamma-aminobutyrate transaminase. Methods Enzymol 113 (1985) 80-82
4. Bakay R.A., and Harris A.B. Neurotransmitter, receptor and biochemical changes in monkey cortical epileptic foci. Brain Res 206 (1981) 387-404
5. Lloyd K.G., Munari C., Worms P., Bossi L., Bancaud J., Talairach J., et al. The role of GABA mediated neurotransmission in convulsive states. Adv Biochem Psychopharmacol 26 (1981) 199-206
6. Butterworth J., Yates C.M., and Simpson J. Phosphate-activated glutaminase in relation to Huntington's disease and agonal state. J Neurochem 41 (1983) 440-447
7. A receptor but not muscarinic receptor density was decreased in the brain of patients with Parkinson's disease. Jpn J Pharmacol 48 (1988) 331-339
8. Aoyagi T., Wada T., Nagai M., Kojima F., Harada S., Takeuchi T., et al. Increased gamma-aminobutyrate aminotransferase activity in brain of patients with Alzheimer's disease. Chem Pharm Bull (Tokyo) 38 (1990) 1748-1749
9. Schwartz-Bloom R.D., and Sah R. Gamma-aminobutyric acid(A) neurotransmission and cerebral ischemia. J Neurochem 77 (2001) 353-371
10. Gunne L.M., Haggstrom J.E., and Sjöquist B. Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis. Nature 309 (1984) 347-349
11. Silverman R.B. Mechanism-based enzyme inactivators. Methods Enzymol 249 (1995) 240-283
12. Nanavati S.M., and Silverman R.B. Design of potential anticonvulsant agents: mechanistic classification of GABA aminotransferase inactivators. J Med Chem 32 (1989) 2413-2421
13. Sarup A., Larsson O.M., and Schousboe A. GABA transporters and GABA-transaminase as drug targets. Curr Drug Targets CNS Neurol Disord 2 (2003) 269-277
14. Gidal B.E., Privitera M.D., Sheth R.D., and Gilman J.T. Vigabatr: a novel therapy for seizure disorders. Ann Pharmacother 33 (1999) 1277-1286
15. Sills G.J., Butler E., Forrest G., Ratnaraj N., Patsalos P.N., and Brodie M.J. Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina. Epilepsia 44 (2003) 886-892
16. Duboc A., Hanoteau N., Simonutti M., Rudolf G., Nehlig A., Sahel J.A., et al. Vigabatrin, the GABA-transaminase inhibitor, damages cone photoreceptors in rats. Ann Neurol 55 (2004) 695-705
17. Izumi Y., Ishikawa M., Benz A.M., Izumi M., Zorumski C.F., and Thio L.L. Acute vigabatrin retinotoxicity in albino rats depends on light but not GABA. Epilepsia 45 (2004) 1043-1048
18. Wilson E.A., and Brodie M.J. Chronic refractory epilepsy may have role in causing these unused lesions. BMJ 314 (1997) 1693
19. Baulac M., Nordmann J.P., and Lanoé Y. Severe visual-field constriction and side-effects of GABA-mimetic antiepileptic agents. Lancet 352 (1998) 546
20. Frosini M., Sesti C., Dragoni S., Valoti M., Palmi M., Dixon H.B., et al. Interactions of taurine and structurally related analogues with the GABA-ergic system and taurine binding sites of rabbit brain. Br J Pharmacol 138 (2003) 1163-1171
21. Cordero F.M., Machetti F., Cacciarini M., and De Sarlo F. Amino-sulfonation of alkenes in a three-component reaction. Eur J Org Chem 8 (2002) 1407-1411
22. Freifelder M., and Wright H.B. Hypocholesteremic agents. II. The hydrogenation of some pyridinesulfonic and pyridinealkanesulfonic acids. J Med Chem 53 (1964) 664-665
23. Fowler L.J., and John R.A. The reaction of ethanolamine O-sulphate with 4-aminobutyrate aminotransferase. Biochem J 197 (1981) 149-154
24. Salvador R.A., and Albers R.W. The distribution of glutamic-gamma-aminobutric transaminase in the nervous system of the rhesus monkey. J Biol Chem 234 (1959) 922-925
25. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
26. 2+ mobilization by hypoxia-induced NO generation in rat brain striatal slices and human astrocytoma U-373 MG cells and its involvement in tissue damage. Eur J Neurosci 17 (2003) 692-700
27. Errante L.D., Williamson A., Spencer D.D., and Petroff O.A. Gabapentin and vigabatrin increase GABA in the human neocortical slice. Epilepsy Res 49 (2002) 203-210
28. Andrew R.D., and Mac Vicar B.A. Imaging cell volume changes and neuronal excitation in the hippocampal slice. Neuroscience 62 (1994) 371-383
29. Forsythe I.D., Tsujimoto T., Barnes-Davies M., Cuttle M.F., and Takahashi T. Inactivation of presynaptic calcium current contributes to synaptic depression at a fast central synapse. Neuron 20 (1998) 797-807
30. Kapetanovic I.M., Yonekawa W.D., and Kupferberg H.J. Time-related loss of glutamine from hippocampal slices and concomitant changes in neurotransmitter amino acids. J Neurochem 61 (1993) 865-872
31. Martin D.L., and Tobin A.J. Mechanisms controlling GABA synthesis and degradation in the brain. In: Martom D.L., and Olsen R.W. (Eds). GABA in the nervous system: the view at fifty years (2000), Lippincott Williams and Wilkins, Philadelphia 25-41
32. Dixon M., and Webb E.C. Enzyme inhibition and activation. In: Dixon M., and Webb E.C. (Eds). Enzymes (1979), Longman, London 332-349
33. Kitz R., and Wilson I.B. Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase. J Biol Chem 237 (1962) 3245-3249
34. Tipton K.F. Enzymes: irreversible inhibition. Nature encyclopedia of life sciences (2001), Nature Publishing Group, London. http://www.els.net/ (http://www.els.net/), doi:10.1038/npg.els.0000601
35. Kalviainen R., and Nousiainen I. Visual field defects with vigabatrin: epidemiology and therapeutic implications. CNS Drugs 15 (2001) 217-230
36. Bazzi M.D., Rabbani N., and Duhaiman A.S. Hydrophobicity of the NADPH binding domain of camel lens zeta-crystallin. Biochim Biophys Acta 1546 (2001) 71-78
37. Frosini M., Ricci L., Saponara S., Palmi M., Valoti M., and Sgaragli G.P. GABA-mediated effects of some taurine derivatives injected i.c.v. on rabbit rectal temperature and gross motor behavior. Amino Acids 30 (2006)
38. B receptors are blocked. J Neurophysiol 93 (2005) 2656-2667
39. Schechter P.J., and Tranier Y. Effect of GABA-transaminase inhibition on rectal temperature in mice. Pharmacol Biochem Behav 6 (1977) 667-669
40. Shuaib A., Ijaz S., Hasan S., and Kalra J. Gamma-vinyl GABA prevents hippocampal and substantia nigra reticulata damage in repetitive transient forebrain ischemia. Brain Res 590 (1992) 13-17
41. B receptors. Eur J Pharmacol 235 (1993) 189-196
42. Wallace A.E., Kline A.E., Montanez S., and Hernandez T.D. Impact of the novel anti-convulsant vigabatrin on functional recovery following brain lesion. Restor Neurol Neurosci 14 (1999) 35-45
43. Krogsgaard-Larsen P., Falch E., Schousboe A., Curtis D.R., and Lodge D. Piperidine-4-sulphonic acid, a new specific GABA agonist. J Neurochem 34 (1980) 756-759
44. Eckstein-Ludwig U., Fei J., and Schwarz W. Inhibition of uptake, steady-state currents, and transient charge movements generated by the neuronal GABA transporter by various anticonvulsant drugs. Br J Pharmacol 128 (1999) 92-102
45. Jacob J.N., Hesse G.W., and Shashoua V.E. Synthesis, brain uptake, and pharmacological properties of a glyceryl lipid containing GABA and the GABA-T inhibitor gamma-vinyl-GABA. J Med Chem 33 (1990) 733-736
46. Storici P., De Biase D., Bossa F., Bruno S., Mozzarelli A., Peneff C., et al. Structures of gamma-aminobutyric acid (GABA) aminotransferase, a pyridoxal 5′-phosphate, and [2Fe-2S] cluster-containing enzyme, complexed with gamma-ethynyl-GABA and with the antiepilepsy drug vigabatrin. J Biol Chem 279 (2004) 363-373
47. Hardus P., Verduin W.M., Engelsman M., Edelbroek P.M., Segers J.P., Berendschot T.T., et al. Visual field loss associated with vigabatrin: quantification and relation to dosage. Epilepsia 42 (2001) 262-267
48. Toggweiler S., and Wieser H.G. Concentric visual field restriction under vigabatrin therapy: extent depends on the duration of drug intake. Seizure 10 (2001) 420-423
49. Hardus P., Engelsman M., van Veelen C.W., and Stilma J.S. Vigabatrin: balancing effectiveness vs. (irreversible) visual field loss as a side effect. Ned Tijdschr Geneeskd 144 (2000) 2066-2069
50. Sills G.J., Patsalos P.N., Butler E., Forrest G., Ratnaraj N., and Brodie M.J. Visual field constriction: accumulation of vigabatrin but not tiagabine in the retina. Neurology 57 (2001) 196-200
51. Neal M.J., Cunningham J.R., Shah M.A., and Yazulla S. Immunocytochemical evidence that vigabatrin in rats causes GABA accumulation in glial cells of the retina. Neurosci Lett 98 (1989) 29-32
52. Roberts J.E. Ocular phototoxicity. J Photochem Photobiol 64 (2001) 136-143
53. Hayes K.C., Carey R.E., and Schmidt S.Y. Retinal degeneration associated with taurine deficiency in the cat. Science 188 (1975) 949-951
54. Wright C.E., Tallan H.H., Lin Y.Y., and Gaull G.E. Taurine: biological update. Annu Rev Biochem 55 (1986) 427-453
55. Bridges C.C., Ola M.S., Prasad P.D., El-Sherbeny A., Ganapathy V., and Smith S.B. Regulation of taurine transporter expression by NO in cultured human retinal pigment epithelial cells. Am J Physiol Cell Physiol 281 (2001) C1825-C1836
56. El-Sherbeny A., Naggar H., Miyauchi S., Ola M.S., Maddox D.M., Martin P.M., et al. Osmoregulation of taurine transporter function and expression in retinal pigment epithelial, ganglion, and muller cells. Invest Ophthalmol Vis Sci 45 (2004) 694-701
57. Rascher K., Servos G., Berthold G., Hartwig H.G., Warskulat U., Heller-Stilb B., et al. Light deprivation slows but does not prevent the loss of photoreceptors in taurine transporter knockout mice. Vis Res 44 (2004) 2091-2100
58. Geggel H.S., Ament M.E., Heckenlively J.R., Martin D.A., and Kopple J.D. Nutritional requirement for taurine in patients receiving long-term parenteral nutrition. N Engl J Med 312 (1985) 142-146
59. Heller-Stilb B., van Roeyen C., Rascher K., Hartwig H.G., Huth A., Seeliger M.W., et al. Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice. FASEB J 16 (2002) 231-233
60. Hillenkamp J., Hussain A.A., Jackson T.L., Cunningham J.R., and Marshall J. Effect of taurine and apical potassium concentration on electrophysiologic parameters of bovine retinal pigment epithelium. Exp Eye Res 82 (2006) 258-264
61. Pasantes-Morales H., and Cruz C. Taurine and hypotaurine inhibit light induced lipid peroxidation and protect rod outer segment structure. Brain Res 330 (1985) 154-157
62. Jeon S.G., Bahn J.H., Jang J.S., Park J., Kwon O.S., Cho S.W., et al. Human brain GABA transaminase tissue distribution and molecular expression. Eur J Biochem 267 (2000) 5601-5607
63. Jeon S.G., Bahn J.H., Jang J.S., Jang S.H., Lee B.R., Lee K.S., et al. Molecular cloning and functional expression of bovine brain GABA transaminase. Mol Cell 12 (2001) 91-96
64. Qiu J., Pingsterhaus J.M., and Silverman R.B. Inhibition and substrate activity of conformationally rigid vigabatrin analogues with gamma-aminobutyric acid aminotransferase. J Med Chem 42 (1999) 4725-4728